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ABSTRACT – Background: The pain, which is involved in Cluster Headache (CH), is ex-
cruciating and is probably one of the most painful conditions known to humans. In the early
70es it was found out that lithium could be used in treating this rare condition. Ekbom pro-
duced his first report of using lithium successfully to treat five cases of CH and this was fol-
lowed later by other studies, which showed the effectiveness of lithium in this condition.
Objective: In this article we reviewed the evidence for using lithium in CH. We discuss
some issues including the duration, the dosage of lithium required and the short and long-
term side effects, which are likely to occur. We also included the mechanism of action of
lithium in treating this condition. 
Methodology: We searched the Medline database from 1950 to date. We included all
studies done in English, which were related to the use of lithium in cluster headache. We
excluded all studies which were not in English and which included other types of headache. 
Results and conclusions: We concluded that lithium is effective in both chronic and
episodic forms of cluster Headache. 
Received 9 January 2008
Revised 2 December 2008
Accepted 11 December 2008
54 M.B. ABDEL-MAKSOUD ET AL.
Introduction
CH is a rare condition, which is charac-
terized by severe explosive pain, which lasts
for less than three hours and occurs mainly
in males. There are two forms of CH name-
ly the chronic and the episodic forms. In the
chronic form, the attacks occur for more
than one year without remission or with re-
mission lasting less than 1 month. In the
episodic form, the attacks occur in periods
lasting 7 days to 1 year separated by pain
free periods lasting 1 month or longer. The
pain is strictly unilateral in the orbital,
supra-orbital, and or temporal region and
associated with ipsilateral cranial autonom-
ic symptoms and signs such as conjunctival
injection, lacrimation, nasal congestion, rhi-
norrhea, miosis, and low grade ptosis. Most
patients are restless or agitated during an at-
tack1. Cluster Headache has been shown to
be associated with dysfunction in the ner-
vous system, notably with involvement of
the hypothalamus. Attacks occur with re-
markable regularity and are related to REM
sleep. They are followed by refractoriness
for few hours and tend to have a seasonal
pattern2.
Graham suggested that the effect of lithi-
um on cluster headache may be, because
this disorder shares several characteristics
with manic depressive disease3.
Studies
Karl Ekbom did the first study when he
treated 5 patients with CH (3 with chronic
CH and 2 with episodic CH). Serum lithium
level was maintained between 0.7& 1.2 m
Eq/l. Lithium was found to be effective in
all 5 patients2.
In another study by Bussone et al., 20 pa-
tients with a diagnosis of chronic CH were
treated with lithium carbonate. The doses of
lithium varied from 900mg to 2.2 gm/day.
All patients improved rapidly on treatment
and once treatment was stopped in some pa-
tients the headache returned within 36
hours4. 
Later on, Kudrow treated a group of 32
patients suffering from chronic CH with
lithium carbonate. The patients had previ-
ously tried different medications including
methysergide, prednisone, and ergotamine
without any result. Serum lithium levels
were maintained lower than 1.2 mEq/l. 27
patients showed a dramatic improvement,
whereas the therapy was found to be inef-
fective in 5 patients5.
Mathew undertook another clinical trial
of lithium carbonate on 31 patients with CH
(14 episodic, and 17 chronic). 80% of the
patients responded to lithium and only 20%
showed no improvement. Effectiveness of
lithium was evident in less than a week after
the initiation of treatment in those who re-
sponded. 55% of patients showed mild side
effects. Treatment was stopped in one pa-
tient only because of intolerable side ef-
fects6.
In a study by Peatfield, 31 patients with
CH were given lithium carbonate and the
serum lithium levels were maintained at
0.6-0.69mmol/l. 14 patients showed a
marked improvement in the first week, and
10 patients showed a lesser improvement7. 
Ekbom gave a further contribution in
1981 when he conducted a study on 19 pa-
tients (8 with chronic CH and 11 with
episodic CH). He tried lithium sulphate and
lithium levels were maintained between 0.7
and 1.2 mmol/l. Immediate partial remis-
sion occurred in all chronic cases. In 4 cases
with episodic CH lithium was continued for
several months which resulted in complete
suppression of cluster periods. The rest of
the patients with episodic CH had slight or
no benefit8. 
In a trial by Faustino Savoldi et al., they
included 90 CH patients (68 with episodic&
22 with chronic symptoms). In the 2nd week
of lithium treatment over 80% of the pa-
tients with chronic CH improved by more
than 90%. In the short term, some side ef-
fects occurred which were mild and tolera-
ble. The doses of lithium varied from 600 to
1200 mg/day and plasma lithium levels var-
ied from 0.3 to 0.8 m Eq/l. Of the 68 pa-
tients with episodic CH, about 3/4 improved
by > 60%. Mild side effects appeared in 18
cases (tremors, thirst, and insomnia). The
plasma level varied from 0.3 to 0.7 m Eq/l9.
Manzoni et al. have investigated the short
and long-term effects of administration of
lithium carbonate (900 mg/day) in 90 pa-
tients with CH (68 episodic and 22 chronic).
50% of the patients with chronic CH (11 pa-
tients) showed a definite improvement,
whereas, 50% had initial or partial improve-
ment only. In 9 cases, cessation of lithium
resulted in reappearance of symptoms. In
the episodic group, 26 patients responded
highly, 26 patients responded partially, and
16 cases were refractory. Reversible goitre
developed in 3 cases after 1-3 years of treat-
ment10.  
A double blind study by Bussone et al.
compared the effect of Lithium and Vera-
pamil in treating CH Showed that both
Lithium and verapamil are effective in pre-
venting Chronic CH. They involved 30 pa-
tients diagnosed with Chronic CH accord-
ing to the International Headache Society
criteria11. Regarding efficacy, both drugs
significantly improved Headache Index
(HI), and Analgesic Consumption (AC). Ve-
rapamil showed > 50% reduction in HI and
58% in AC & Lithium showed > 37% and
58% respectively in the 1st week. Regarding
Side effects, both drugs showed minor side
effects (12% for verapamil and 29% for
lithium)12.         
Steiner et al. conducted a double blind,
placebo-controlled comparison of matched
parallel groups of patients with episodic CH
where treatment was slow release lithium
carbonate, 800 mg/day, or placebo. Substan-
tial improvement occurred in 8/13(62% NS)
on lithium and 6/14 (43%) on placebo and
the trial was stopped because superiority of
lithium could not be demonstrated13.   
There are other case reports which
showed the effectiveness of lithium carbon-
ate in treating both forms of CH. Wyant &
Ashenhurst reported five cases of patients
who had a diagnosis of CH(4 chronic and 1
episodic). They tried lithium carbonate and
later on added amitriptyline for patients
with chronic CH and lithium carbonate only
for the patient with episodic CH. Complete
remission occurred in the patient with
episodic CH and 1 patient with chronic CH.
A significant improvement occurred in 3 pa-
tients with chronic CH14.
In 1978, Lieb & Zeff reported two cases
with severe chronic CH to the extent that
they had suicidal ideations. Both cases re-
sponded dramatically to lithium carbonate
with serum levels of 0.76 - 1.15 mEq/l15. 
Kilmek et al. used lithium carbonate to
treat 15 patients with CH (8 chronic and 7
episodic). In all cases lithium serum level
was maintained at 0.6-1.2 mmol/l. Disap-
pearance of symptoms occurred in 5 pa-
tients (1 chronic and 4 episodic) and signifi-
cant improvement occurred in 5 patients (4
chronic and 1 episodic). The treatment was
ineffective in 5 patients (3 chronic and 2
episodic)16. 
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In an open trial, Damasio & Lyon tried
lithium carbonate on 21 patients with CH (9
episodic, 12 chronic). 52.4% (n = 11) of pa-
tients showed absolute improvement, 23.8%
(n = 5) showed partial improvement, and
23.8% (n = 5) did not improve or had tempo-
rary improvement only. Two patients had to
discontinue treatment due to side effects17. 
J M S Pearce reported 3 cases of episodic
CH which responded dramatically to lithium
carbonate at a dose of 250mg tds. No side ef-
fects were observed from lithium use18.
In 1980, Manzoni and Terzano tried lithium
carbonate at gradually increased doses in 6
patients with chronic CH. The effective dose
of lithium varied from 300 to 900mg/day19.
Zuddas et al. reported a case of chronic CH
on haemodialysis treatment where lithium
was used and led to a complete recovery20.
Mechanism of action of
lithium
Some trials have been undertaken in an
attempt to understand how lithium works in
patients with Cluster Headache.
Kupfer et al.21 and Mendels & Chernik22
reported that the immediate action of lithi-
um in treating CH is related to its effect on
REM sleep. 
In another study by Medina et al., it was
found that lithium effect on CH is related to
its effect on platelet serotonin and histamine
levels23.  
It was also suggested that lithium action
in CH can be attributed to its effect on opi-
ate receptor affinity24.
Giacovazzo et al. studied the relationship
between genetic markers of patients with
CH and the therapeutic efficacy of lithium.
In this study, 35 patients with episodic CH
were involved. Lithium level was kept be-
tween 0.7 and 1.2 mEq/l. Two subgroups
were identified (responders n = 21 and non
responders n = 14). Responders displayed a
higher frequency of the antigens HLA-B18
and HLA-A9 than did the non responders.
The latter, on the other hand, showed a high-
er frequency of HLA-A1 than did the re-
sponders25.
It was also found that lithium can correct
the bilateral neuronal asymmetries which
are related to the pathogenesis of CH26.
In a study by De Bellaroche et al., it was
found that lithium restored the erythrocyte
choline concentrations which were marked-
ly reduced in patients with CH. This finding
was consistent with a subsequent study
which showed a decreased turnover in the
erythrocyte phosphatidylcholine in CH suf-
ferers27,28.
Winter et al. suggested that the mecha-
nism of action of lithium in CH lies behind
its antiviral actions29. This was based on the
theory which suggests an association be-
tween CH and herpes simplex30.
A study by G Chazot et al. showed the
chronobiological effect of lithium in cluster
headache. The result showed a decrease in
melatonin amplitude at day 0 in the cluster
group together with a rise in the cortisol.
However in day 7 there was a delay in mela-
tonin secretion with a shift but clear in-
crease of the acrophase was observed. A de-
crease in cortisol level was also observed31.
The cyclic nature and hormonal alter-
ations in CH indicate the involvement of the
hypothalamus in the pathogenesis of this
disorder. One possible mechanism of action
of lithium is its effect on the serotonin level
in the hypothalamus32.
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Discussion
We concluded from our review that lithi-
um can be effective in both types of cluster
headache but, perhaps, the evidence of its
effectiveness in episodic forms is rather
controversial. Some authors found that
there is a decrease in the effectiveness of
lithium after prolonged use in this condi-
tion. This may be due to tolerance or lack
of compliance for one reason or another.
There is a controversy regarding the re-
quired dose of lithium in patients with CH
and some authors required higher doses to
reach a plasma level between 0.7-1.2
mmol/l. Others, on the other hand, found
that low doses of lithium with plasma levels
between 0.4-1.0 mmol/l should be adequate
for this condition. 
In the short term the side effects of lithi-
um are generally tolerable and they are
mainly in the form of fine hand tremors,
polyurea, and polydypsia. In the long term,
hypothyroid goitre and renal impairment
may develop. Hypothyroidism secondary to
long-term lithium treatment can be treated
and should not be an indication to stop lithi-
um in stable clients. It is important that pa-
tients be well informed as to the needs for
periodic lithium blood level determinations
and the adverse as well as the beneficial ef-
fects of the drug.
It should be noted that with exception of
the two studies done by Bussone et al.12,
and Steiner et al.13, results have been de-
rived solely from open clinical trials. 
Although there are different theories be-
hind the mechanism of action of lithium in
treating CH, however, it remains unclear to
how exactly it works and produces its rapid
effect in this condition. 
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